Cargando…
Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
Drug development and preclinical trials are challenging processes and more than 80% to 90% of drug candidates fail to gain approval from the United States Food and Drug Administration. Predictive and efficient tools are required to discover high quality targets and increase the probability of succes...
Autor principal: | Lee, Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131519/ https://www.ncbi.nlm.nih.gov/pubmed/25143803 http://dx.doi.org/10.4062/biomolther.2014.074 |
Ejemplares similares
-
INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022) -
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016) -
Tree breeding, a necessary complement to genetic engineering
por: Nelson, C. Dana
Publicado: (2022) -
Preclinical animal anxiety research – flaws and prejudices
por: Ennaceur, Abdelkader, et al.
Publicado: (2016) -
The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation
por: Cooper, David K.C., et al.
Publicado: (2013)